---
description: Per-task adversarial semantic verification for TASK-025 backend cart merge acceptance suite.
status: complete
---
# TASK-025 Red Verification

SEMANTIC_VERDICT: semantic-pass

## Mode And Status

- Mode: manual per-task `/red-verify TASK-025`.
- Tier: T3.
- Scope: backend acceptance suite semantics, evidence quality, boundary fit, and
  T3 safety concerns.
- Status ownership: no task closure was requested; task status remains unchanged.
- Closure note: T3 closure still requires `HUMAN_CHECKPOINT: done` and
  `ROLLBACK_RECOVERY_NOTE: present` by a scheduler or explicit closure owner.

## Top Substance Risks Checked

- False success via browser mocks: not found. The suite executes through Medusa
  route, workflow, module services, Cart Module, synthetic customers/carts, and
  PostgreSQL-backed runtime.
- Test-only production behavior drift: not found. TASK-025 adds an acceptance
  script and runner registration, not merge route/workflow/module behavior.
- Ownership/security shortcut: not found. The suite verifies foreign-owned source
  denial, actor-bound replay, and no client-chosen destination/customer.
- Data-loss false confidence: not found. The suite proves no mutation on stock
  conflict, no duplicate quantity on replay, consumed-source not-found behavior,
  and source/target restoration after injected post-soft-delete failure.
- Scope drift into OAuth, storefront, checkout, order, inventory reservation,
  payment, production data, or live secrets: not found.

## False-Success And Purpose Fit

- Purpose fit: pass. TASK-025's purpose is independent server-side acceptance
  evidence for the data/security boundary, and the evidence is independent of
  browser UI or OAuth providers.
- Success outcome fit: pass. REQ-008 backend merge behavior is proven against the
  real Medusa/PostgreSQL boundary for transfer, deterministic target selection,
  same-variant summing, replay, consumed-source, and recovery semantics.
- Evidence quality: pass. The command output reports all task-specific boolean
  assertions as true and the runner source boundary as
  `medusa-route-workflow-module-postgresql`.

## Anti-Goal And Scope Assessment

- Anti-goals respected: no production merge behavior changes, live providers,
  production data, or browser UI coverage were added.
- Allowed write scope respected for implementation: backend package script,
  backend integration runner, backend smoke script, and Memory Bank changelog.
- Forbidden scope touched: no evidence found.

## Cross-Boundary Impact

- API boundary: the suite calls the Store merge route handler with authenticated
  customer context and an empty request body; it does not introduce client-side
  destination/customer authority.
- Workflow/module boundary: the suite delegates to existing TASK-019/TASK-020
  planning/lifecycle and Cart Merge Module semantics rather than duplicating
  merge logic.
- Data boundary: the suite uses Medusa Cart Module/PostgreSQL as cart truth and
  Cart Merge Module journal state for replay and recovery evidence.
- Feature boundary: browser persistence and real-browser acceptance remain
  TASK-026; OAuth providers remain FT-004.

## Architectural, State, And Operational Concerns

- Architecture: no new service, queue, cache, middleware wrapper, or Medusa Core
  modification is introduced.
- State/data consistency: tested paths include transfer, merge, target isolation,
  same-variant summing, foreign denial, stock no-mutation, replay no-duplication,
  pending-journal in-progress behavior, consumed-source not-found, and restore
  compensation.
- Runtime/production concerns: the script uses synthetic local fixtures and no
  secrets; it should remain a local/staging integration command, not a production
  operational command.
- Maintenance cost: acceptable. The new suite follows the existing backend smoke
  script pattern and runner registration.

## Hidden Assumptions And Residual Risks

- The consumed-source Store CRUD claim is primarily proven through the Medusa Cart
  Module soft-delete boundary; if a future Store route bypassed that module, a
  route-level CRUD regression could need an additional acceptance check.
- The concurrency proof validates the pending-journal/in-progress response path,
  not a high-load race harness. This matches current task evidence expectations.
- The suite assumes seeded local RUB region, default sales channel, and a
  sellable canonical variant; seed drift would make the test fail rather than
  silently pass.
- Running any destructive smoke script against production configuration would be
  unsafe operationally, but this task used synthetic local data and introduced no
  production deploy/runtime command.

## How This Could Still Be Wrong

- If Medusa Store CRUD routes later stop honoring Cart Module soft-delete
  semantics, module-level not-found evidence would no longer be sufficient.
- If future inventory/sellability fixtures change so `60 + 60` is sellable, the
  stock-conflict assertion would fail and require fixture adjustment.
- If TASK-026 or feature-level verification finds a browser/auth integration
  mismatch, TASK-025 may still be semantically correct as backend acceptance but
  not enough for FT-003 completion.

## Counterproposal / Escalation Path

- No blocker or follow-up is required for TASK-025 semantic acceptance.
- If the project wants stricter route-level CRUD proof beyond current scope,
  add a focused follow-up acceptance check for retrieve/add/update/remove against
  a consumed source through Store route handlers.
- Next normal T3 steps: record closure markers under an explicit closure owner,
  then `/mb-sync`; FT-003 still needs TASK-026 and feature-level
  `/red-verify --feature FT-003` before feature completion.

## Commands Re-Run

- PASS: `npm --workspace apps/backend run test:integration -- cart-merge-acceptance`
- PASS: `npm --workspace apps/backend run typecheck`
- PASS: `node scripts/mb-lint.mjs`
- PASS: `node scripts/mb-doctor.mjs --strict`

## Verdict

Per-task semantic verification passes. TASK-025 is closure-eligible only after an
explicit scheduler/closure owner also records required T3 human and
rollback/recovery markers.
